Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

5.75p
   
  • Change Today:
    -0.13p
  • 52 Week High: 23.00
  • 52 Week Low: 3.13
  • Currency: UK Pounds
  • Shares Issued: 143.14m
  • Volume: 1,057,288
  • Market Cap: £8.23m
  • RiskGrade: 747

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
12.17% above the market average12.17% above the market average12.17% above the market average12.17% above the market average12.17% above the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
89.93% above the market average89.93% above the market average89.93% above the market average89.93% above the market average89.93% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Book Ratio
76.17% below the market average76.17% below the market average76.17% below the market average76.17% below the market average76.17% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
98.46% above the market average98.46% above the market average98.46% above the market average98.46% above the market average98.46% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average
Price Chg 3m
66.05% below the market average66.05% below the market average66.05% below the market average66.05% below the market average66.05% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
56.34% above the market average56.34% above the market average56.34% above the market average56.34% above the market average56.34% above the market average
47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average47.06% above the sector average
Momentum 20
49.51% above the market average49.51% above the market average49.51% above the market average49.51% above the market average49.51% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
98.1% below the market average98.1% below the market average98.1% below the market average98.1% below the market average98.1% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
76.36% below the market average76.36% below the market average76.36% below the market average76.36% below the market average76.36% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
94.96% below the market average94.96% below the market average94.96% below the market average94.96% below the market average94.96% below the market average
93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average93.75% below the sector average
Operating Profit Loss
70.29% below the market average70.29% below the market average70.29% below the market average70.29% below the market average70.29% below the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
61.97% below the market average61.97% below the market average61.97% below the market average61.97% below the market average61.97% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average
Cash
40.85% below the market average40.85% below the market average40.85% below the market average40.85% below the market average40.85% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 5.75p
Change Today -0.13p
% Change -2.13 %
52 Week High 23.00
52 Week Low 3.13
Volume 1,057,288
Shares Issued 143.14m
Market Cap £8.23m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.03% below the market average43.03% below the market average43.03% below the market average43.03% below the market average43.03% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average
Price Trend
90.26% below the market average90.26% below the market average90.26% below the market average90.26% below the market average90.26% below the market average
67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average67.57% below the sector average
Income Not Available
Growth
45.78% below the market average45.78% below the market average45.78% below the market average45.78% below the market average45.78% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Genedrive Dividends

No dividends found

Trades for 17-Apr-2024

Time Volume / Share Price
17:07 181,570 @ 5.75p
16:35 38,500 @ 5.75p
16:35 38,500 @ 5.75p
16:29 100 @ 5.86p
16:12 32,268 @ 6.15p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page